Pilot of Zinc Acetate to Improve Chronic Cough

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

December 11, 2019

Study Completion Date

December 11, 2019

Conditions
Cough
Interventions
DRUG

Zinc Acetate 50 Mg Oral Capsule

"* Day 0 (randomization) to day 3 Zinc acetate 50 mg per day (one capsule)~* Day 4 to day 7 If well tolerated: Zinc acetate 100 mg per day (two capsules)~* Day 8 to V5 (6 weeks) If well tolerated: Zinc acetate 150 mg per day (three capsules)"

DRUG

Placebo oral capsule

"* Day 0 (randomization) to day 3 Placebo (one capsule per day)~* Day 4 to day 7 If well tolerated: placebo (two capsules per day)~* Day 8 to V5 (6 weeks) If well tolerated: placebo (three capsules per day)"

Trial Locations (5)

10029

Mount Sinai School of Medicine, New York

27710

Duke University Medical Center, Durham

46260

St. Vincent Health, Indianapolis

63110

Washington University School of Medicine, St Louis

80206

National Jewish Medical and Research Center, Denver

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Lung Association

OTHER

lead

Johns Hopkins University

OTHER

NCT03135522 - Pilot of Zinc Acetate to Improve Chronic Cough | Biotech Hunter | Biotech Hunter